Adenosine Deaminase Shows Promise in Reversing Age-Related Vaccine Immune Deficiency in Mice
Researchers found that co-delivering adenosine deaminase (ADA) with a DNA vaccine against Clostridioides difficile restored immune responses in aged mice to levels comparable to young adults. Older adults are disproportionately vulnerable to C. difficile infection, and existing vaccines perform poorly in aged hosts due to well-documented declines in CD4+ T cell and germinal center function. The findings identify ADA as a potential 'metabolic adjuvant' that could improve vaccine efficacy in elderly populations by correcting adenosine-driven immunosuppression.
A preprint study posted to bioRxiv reports that co-immunization with plasmid-encoded adenosine deaminase-1 (pADA) reversed multiple age-associated immune defects in a mouse model of Clostridioides difficile vaccination. Aged mice receiving only the DNA vaccine targeting toxin A and B receptor binding domains (pRBD) showed markedly reduced toxin-specific CD4+ T cells, impaired T follicular helper (TFH) cell activation, and poor toxin A neutralization relative to young mice. Adding pADA to the vaccine regimen restored CD4+ T cell generation, cytokine production, TFH activation, and antibody-mediated neutralization to levels seen in young animals. Mechanistically, pADA co-immunization reduced expression of CXCR4 on germinal center TFH cells — an age-related defect linked to impaired germinal center positioning and reduced B cell help — and lowered adenosine concentrations in aged lymph nodes. These immune improvements translated into better clinical outcomes, including reduced morbidity, mortality, and weight loss following live C. difficile spore challenge in aged mice. The authors propose that adenosine-dependent CXCR4 regulation represents a tractable target for improving vaccine responses in older adults.
What's missing
As a preprint, this study has not yet undergone peer review. All experiments were conducted in mice, and it remains unknown whether pADA co-immunization produces comparable immune restoration in aged humans. The study does not address potential safety concerns of systemic adenosine depletion, optimal dosing, or long-term durability of the restored immune responses. It is also unclear whether the approach would generalize to other vaccines beyond the C. difficile DNA vaccine platform tested.
What different sources said
- bioRxivCenter
Adenosine deaminase co-immunization reverses age-associated immunosenescence by restoring germinal center T follicular helper cell function
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.